Nanollose Ltd (ASX: NC6) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Nanollose Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$3.27 million
P/E Ratio
N/A
Dividend Yield
0.00%
Shares Outstanding
197.01 million
Earnings per share
-0.007
Dividend per share
N/A
Year To Date Return
-13.64%
Earnings Yield
N/A
Franking
-
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Nanollose Ltd (ASX: NC6)
Latest News
Share Market News
Why the Nanollose (ASX:NC6) share price is shooting higher today
NC6 ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Nanollose Ltd
Nanollose Ltd is a biomaterials company, commercialising technology to create fibres, fabrics, and other materials with minimal environmental impact. Its principal activities include research and development, and promotion of the Company'smicrobial cellulose technologies. The company is engaged in development and commercialisation of its Tree-Free rayon fibre for use in textiles (Nullarbor) and non-woven applications (Nufolium).
NC6 Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 23 Dec 2024 | $0.02 | $0.00 | 0.00% | 126,444 | $0.02 | $0.02 | $0.02 |
| 20 Dec 2024 | $0.02 | $0.00 | 0.00% | 313,547 | $0.02 | $0.02 | $0.02 |
| 19 Dec 2024 | $0.02 | $0.00 | 0.00% | 205,214 | $0.02 | $0.02 | $0.02 |
| 18 Dec 2024 | $0.02 | $0.00 | 0.00% | 324,439 | $0.02 | $0.02 | $0.02 |
| 17 Dec 2024 | $0.02 | $0.00 | 0.00% | 674,032 | $0.02 | $0.02 | $0.02 |
| 16 Dec 2024 | $0.02 | $0.00 | 0.00% | 1,789,653 | $0.02 | $0.02 | $0.02 |
| 13 Dec 2024 | $0.02 | $-0.01 | -33.33% | 1,799,079 | $0.03 | $0.03 | $0.02 |
| 11 Dec 2024 | $0.03 | $0.00 | 0.00% | 108,333 | $0.03 | $0.03 | $0.03 |
| 10 Dec 2024 | $0.03 | $0.00 | 0.00% | 74,185 | $0.03 | $0.03 | $0.03 |
| 09 Dec 2024 | $0.03 | $0.00 | 0.00% | 344,678 | $0.03 | $0.03 | $0.03 |
| 06 Dec 2024 | $0.03 | $0.00 | 0.00% | 45,070 | $0.03 | $0.03 | $0.03 |
| 05 Dec 2024 | $0.03 | $0.00 | 0.00% | 57,103 | $0.03 | $0.03 | $0.03 |
| 04 Dec 2024 | $0.03 | $0.00 | 0.00% | 275,986 | $0.03 | $0.03 | $0.03 |
| 03 Dec 2024 | $0.03 | $0.01 | 45.45% | 26,732 | $0.03 | $0.03 | $0.03 |
| 02 Dec 2024 | $0.02 | $0.00 | 0.00% | 999,557 | $0.02 | $0.02 | $0.02 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 13 Dec 2024 | Wayne Best | Expiry | 1,000,000 | $19,000 |
Options expired.
|
| 30 May 2024 | Wayne Best | Expiry | 1,000,000 | $24,000 |
As advised by the company. lapsed, 2,000,000 Rights
|
| 06 Feb 2024 | Winton Willesee | Issued | 1,200,000 | $30,000 |
Participation in share purchase plan.
|
| 06 Feb 2024 | Winton Willesee | Issued | 1,200,000 | $26,400 |
Participation in share purchase plan.
|
| 06 Feb 2024 | Wayne Best | Issued | 1,200,000 | $30,000 |
Participation in share purchase plan.
|
| 06 Feb 2024 | Wayne Best | Issued | 1,200,000 | $26,400 |
Participation in share purchase plan.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Winton William Willesee | Non-Executive Director | Sep 2014 |
Mr Willesee is a company director with over 20 years of experience in various roles within the Australian capital markets. Mr Willesee has experience with ASX listed and other companies over a broad range of industries having been involved with many successful ventures from early stage through to large capital development projects. He has expertise in strategy, company development, corporate governance, company public listings, merger and acquisition transactions and corporate finance.
|
| Dr Wayne Morris Best | Executive ChairmanExecutive Director | Sep 2014 |
Dr Best has 40 years of experience in organic chemistry both in academia, government and industry. He took up a position with ICI Australia's Research Group in Melbourne for four and a half years which included a secondment to ICI Agrochemicals in the UK. Following ICI, Wayne returned to Western Australia and spent ten years at the Chemistry Centre (WA) where he was responsible for the formation and running of the Medicinal & Biological Chemistry Section which undertook collaborative R&D into drug discovery and contract synthesis for the drug discovery and pharmaceutical industries. He then founded Epichem Pty Ltd, a contract research and drug discovery Company, which he managed for 14 years before moving full-time to Nanollose in 2018 He has served as a director for several listed and unlisted biotechnology companies.
|
| Ms Heidi Beatty | Non-Executive Director | Jul 2019 |
Ms Beatty, founder of Crown Abbey Ltd is a scientist and innovator who has 20 years of experience developing consumer and health care products. After gaining a BSc in Chemistry from the University of York UK, Heidi worked with Johnson & Johnson for 10 years in Europe and the US. In 2015 Heidi founded Crown Abbey Ltd, a consultancy company that supports clients in their project launches, combining Project Management and Product Development across Consumer and Healthcare categories.
|
| Mrs Erlyn Dawson | Company Secretary |
-
|
|
| Erlyn Dawson | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Azalea Family Holdings Pty Ltd <No 2 A/C> | 9,200,000 | 5.35% |
| Mr Shane Raffa | 8,300,000 | 4.83% |
| Wayne Morris Best <Wayne & Debra Best Fam A/C> | 7,725,002 | 4.49% |
| Mr Jason Duncan Maclaurin | 6,351,190 | 3.69% |
| Citicorp Nominees Pty Limited | 6,005,832 | 3.49% |
| Mr John Moursounidis <Moursounidis Family A/C> | 5,934,523 | 3.45% |
| Madeiros Pty Ltd <Visser Super Fund A/C> | 3,805,015 | 2.21% |
| Mr Dean Anthony Mackenzie | 3,481,540 | 2.02% |
| Mr Bryant James McLarty <The McLarty Family A/C> | 3,459,973 | 2.01% |
| Mr Adam Laurence Bode | 3,356,240 | 1.95% |
| BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient> | 3,087,332 | 1.79% |
| Tripit Pty Ltd <Peter Heather Wells S/F A/C> | 3,000,000 | 1.74% |
| Mr Andreas Steinwachs | 2,500,000 | 1.45% |
| Mr Shorsh Salehi | 2,297,492 | 1.34% |
| Mr Bertrand Lalanne | 2,250,000 | 1.31% |
| Mr Tak Wai Chow | 2,198,893 | 1.28% |
| Gman (WA) Pty Ltd <Gman Family A/C> | 1,800,000 | 1.05% |
| Mr Anthony West | 1,756,193 | 1.03% |
| Mr David Robin Lunn & Mrs Stephanie Ann Yu <Lunn Superfund A/C> | 1,722,097 | 1.00% |
| Mr Brad Franken <BS & EA Franken Family A/C> | 1,700,000 | 0.99% |
